BioCentury
ARTICLE | Clinical News

Velcade bortezomib: Phase II data

May 25, 2009 7:00 AM UTC

Data from the Phase II VERTICAL trial in 15 evaluable patients receiving Velcade plus Treanda bendamustine and Rituxan rituximab showed that there were 2 cases of dose-limiting toxicities: severe ra...